Warning: Creating default object from empty value in /home/stepadmin/public_html/wp-content/themes/salient/nectar/redux-framework/ReduxCore/inc/class.redux_filesystem.php on line 29
Andrew Ingram – Stepworks

Notice: Trying to access array offset on value of type bool in /home/stepadmin/public_html/wp-content/themes/salient/nectar/helpers/media.php on line 380
All Posts By

Andrew Ingram

COVID Update | Family Visitation

By Stepworks Connect

Stepworks is currently monitoring the coronavirus (COVID-19) pandemic and has a plan in place to prepare for and respond to any health and safety issues that may impact the organization. As the situation evolves, our priority remains the health and well-being of our employees and patients.  

Because of this, we are suspending all visitation for our patients at this time. Stepworks understands the hardships that this places on our patients and their families, but everyone’s safety needs to be the priority at this time. 

In place of visitation, patients will be allowed to sign up for extended phone time with their family members. Additionally, Skype or FaceTime sessions will be scheduled to allow for our patients and their families to connect. Patients will be given time over the next week to reach out to their families to schedule tele-visits and choose a mode of communication for these visits.

Stepworks Facility Extensions
Stepworks of London: 800-545-9031, Ext. 2100
Stepworks of Bowling Green: 800-545-9031, Ext. 2200
Stepworks Woodland Dr: 800-545-9031, Ext. 2300
Stepworks Crowne Pointe: 800-545-9031, Ext. 2400
Stepworks of Nicholasville: 800-545-9031, Ext. 2500

To download a free Skype account, please visit this link:
https://www.skype.com/en/get-skype/

Coronavirus Disease (COVID-19) Response

By Stepworks Connect

At Stepworks we understand that COVID-19 (or coronavirus) has everyone concerned. While information regarding the virus is changing rapidly, we want you to know the steps that Stepworks is taking to minimize the disruption within our facilities and answer a few questions.

First: Are we accepting new patients?

The answer is yes. While coronavirus presents some significant health challenges, the reality is that addiction, or substance use disorder, is a life-threatening disease. In fact, hundreds of people die daily from overdose deaths alone. So, while we are implementing some safeguards for our patients and staff to address COVID-19, we are also committed to providing life-saving treatment services for our patients and families. To put it simply, addiction doesn’t stop because of coronavirus, so neither are we.

Read More

Changes in Addiction Treatment with A. Thomas McLellan, Ph.D.

By Stepworks Connect No Comments

Stepworks is proud to present the first in a special series of speakers on addiction education, treatment, and technology. You can find this special series and future resources and events through Stepworks Connect, a new free source of podcasts, videos, and other educational supplements. Through Stepworks Connect, we hope to help educate the public and medical community on the disease of addiction and cutting-edge treatment solutions.

Changes in Addiction Treatment with A. Thomas McLellan

This month, Dr. A. Thomas McLellan discusses how recent policy changes in insurance coverage have created new opportunities for prevention, early intervention, and treatment of substance use disorders. Dr. McLellan is among the foremost names in substance use research and public policy, having published over 400 articles of addiction research. He founded the Treatment Research Institute (TRI) and has worked as Science Advisor and Deputy Director of the White House Office of National Drug Control Policy. The presentation will include an overview of recent health insurance policy changes and cover key issues for clinical and administrative personnel dealing with substance use problems in clinical populations.

Registration

addiction treatment

The Live Event

September 14, 2015
9:30 a.m. – 12:30 p.m.

Chrysalis Community Center
1589 Hill Rise Drive, Lexington, KY 40504

About the Speaker

A. Thomas McLellan, Ph.D. is the founder of the Treatment Research Institute (TRI) and an experienced substance abuse researcher. From 2009 to 2010, he was Science Advisor and Deputy Director of the White House Office of National Drug Control Policy (ONDCP), a congressionally confirmed Presidential appointment to help shape the nation’s public policy approach to illicit drug use. At ONDCP, Dr. McLellan worked on a broad range of drug issues, including formulation and implementation of the President’s National Drug Control Strategy and promotion of drug treatment through the broader revamping of the national health care system.

Dr. McLellan has more than 35 years of experience in addiction treatment research. In 1992, he co-founded and led TRI (until his ONDCP appointment) to transform the way research is employed in the treatment of and policy-making around substance use and abuse. In his career he has published over 400 articles and chapters on addiction research. From 2000-2009 he was Editor-in-Chief of the Journal of Substance Abuse Treatment, and he has also served on several other editorial boards of scientific journals. Dr. McLellan is the recipient of several distinguished awards, including the Life Achievement Awards of the American and British Societies of Addiction Medicine (2001 & 2003); the Robert Wood Johnson Foundation Innovator Award (2005); and awards for Distinguished Contribution to Addiction Medicine from the Swedish (2002) and Italian (2002) Medical Associations.

In the 1980s, with his colleagues from the Center for the Studies of Addiction at the University of Pennsylvania, Dr. McLellan introduced the Addiction Severity Index and, later, the Treatment Services Review. Both are among the most widely used assessment instruments in the world.

Our topics of discussion will include:

  • Innovations in screening and brief intervention: applications in school systems and primary care
  • Harm-reduction methods: what they are and why they are so controversial
  • Maintenance medications
  • Overdose prevention and reversal
  • Syringe exchange
  • Creating welcoming treatment environments that engage and retain patients
  • Technological and administrative solutions

All training series events will be recorded and available for later viewing.

Proudly sponsored by: